Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Department of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231 Bad Nauheim, Germany.
J Biol Chem. 2010 May 14;285(20):15137-15148. doi: 10.1074/jbc.M109.072843. Epub 2010 Mar 11.
We have previously shown a novel link between hPar-1 (human protease-activated receptor-1) and beta-catenin stabilization. Although it is well recognized that Wnt signaling leads to beta-catenin accumulation, the role of PAR1 in the process is unknown. We provide here evidence that PAR1 induces beta-catenin stabilization independent of Wnt, Fz (Frizzled), and the co-receptor LRP5/6 (low density lipoprotein-related protein 5/6) and identify selective mediators of the PAR1-beta-catenin axis. Immunohistological analyses of hPar1-transgenic (TG) mouse mammary tissues show the expression of both Galpha(12) and Galpha(13) compared with age-matched control counterparts. However, only Galpha(13) was found to be actively involved in PAR1-induced beta-catenin stabilization. Indeed, a dominant negative form of Galpha(13) inhibited both PAR1-induced Matrigel invasion and Lef/Tcf (lymphoid enhancer factor/T cell factor) transcription activity. PAR1-Galpha(13) association is followed by the recruitment of DVL (Dishevelled), an upstream Wnt signaling protein via the DIX domain. Small interfering RNA-Dvl silencing leads to a reduction in PAR1-induced Matrigel invasion, inhibition of Lef/Tcf transcription activity, and decreased beta-catenin accumulation. It is of note that PAR1 also promotes the binding of beta-arrestin-2 to DVL, suggesting a role for beta-arrestin-2 in PAR1-induced DVL phosphorylation dynamics. Although infection of small interfering RNA-LRP5/6 or the use of the Wnt antagonists, SFRP2 (soluble Frizzled-related protein 2) or SFRP5 potently reduced Wnt3A-mediated beta-catenin accumulation, no effect was observed on PAR1-induced beta-catenin stabilization. Collectively, our data show that PAR1 mediates beta-catenin stabilization independent of Wnt. We propose here a novel cascade of PAR1-induced Galpha(13)-DVL axis in cancer and beta-catenin stabilization.
我们之前已经证明了 hPar-1(人蛋白酶激活受体-1)与β-catenin 稳定之间存在新的联系。尽管众所周知 Wnt 信号会导致β-catenin 积累,但 PAR1 在该过程中的作用尚不清楚。我们在这里提供的证据表明,PAR1 可诱导β-catenin 稳定,而不依赖于 Wnt、Fz(Frizzled)和辅助受体 LRP5/6(低密度脂蛋白受体相关蛋白 5/6),并确定了 PAR1-β-catenin 轴的选择性介质。对 hPar1 转基因(TG)小鼠乳腺组织的免疫组织学分析显示,与年龄匹配的对照物相比,同时表达了 Galpha(12)和 Galpha(13)。然而,只有 Galpha(13)被发现积极参与 PAR1 诱导的β-catenin 稳定。事实上,一种 Galpha(13)的显性负形式抑制了 PAR1 诱导的 Matrigel 侵袭和 Lef/Tcf(淋巴增强因子/T 细胞因子)转录活性。PAR1-Galpha(13)的结合后,通过 DIX 结构域招募了 Wnt 信号蛋白 DVL(Dishevelled)。小干扰 RNA-Dvl 沉默导致 PAR1 诱导的 Matrigel 侵袭减少、Lef/Tcf 转录活性抑制和β-catenin 积累减少。值得注意的是,PAR1 还促进了β-arrestin-2 与 DVL 的结合,表明β-arrestin-2 在 PAR1 诱导的 DVL 磷酸化动力学中起作用。尽管感染小干扰 RNA-LRP5/6 或使用 Wnt 拮抗剂 SFRP2(可溶性 Frizzled 相关蛋白 2)或 SFRP5 可显著降低 Wnt3A 介导的β-catenin 积累,但对 PAR1 诱导的β-catenin 稳定没有影响。总的来说,我们的数据表明,PAR1 介导的β-catenin 稳定不依赖于 Wnt。我们在这里提出了一种新的 PAR1 诱导的 Galpha(13)-DVL 轴在癌症中的级联反应和β-catenin 稳定。